Manica Balasegaram

Manica Balasegaram

politician Unknown

Dr. Manica Balasegaram is the executive director of the Global Antibiotic Research and Development Partnership and has been instrumental in the development and clinical trials of new treatments for gonorrhea, emphasizing the importance of accessible treatment amid rising drug resistance.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United Kingdom United Kingdom: Dr Manica Balasegaram, executive director of GARDP, stated that the approval marks a huge turning point in the treatment of multidrug-resistant gonorrhoea. 9

The Guardian: New antibiotics hailed as ‘turning point’ in treating drug-resistant gonorrhoea | Global health

United States United States: Dr. Manica Balasegaram, executive director of the Global Antibiotic Research and Development Partnership, highlighted the advantages of the new treatment options. 9

CNN: FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

United Kingdom United Kingdom: Dr Manica Balasegaram is executive director of the Global Antibiotic Research and Development Partnership. 8

The Guardian: ‘As new infections outpace new drugs, are we sleepwalking into a global health disaster?’ | Dr Manica Balasegaram